
Average penis size has increased — and Ozempic could be to blame, experts say
Ozempic might shrink waistlines, but it seems to bulge another body part.
In a recent Reddit thread, male Ozempic users claimed that the weight-loss drugs helped their penises grow.
'I recently measured myself down there and noticed I gained about one inch,' a person proudly shared on the forum.
Advertisement
Although there hasn't been enough research done on the correlation between semaglutide and men's genitalia measurements — the average penis size is continuing to rise, and some experts think Ozempic might actually have something to do with it.
The average penis has grown nearly 10% from 5.17 inches to 5.63 between 2022 and 2024 in the UK, according to diabetes.co.
And they're not the only ones seeing this increase.
Advertisement
The data also revealed that Venezuelan men experienced a massive increase from 1.42 inches to 6.67 inches, within those two years.
Dr. Richard Viney, a consultant urological surgeon at the Queen Elizabeth Hospital in Birmingham, thinks Ozempic and similar drugs could be to blame.
'Men's penises shorten as they get older (due to) increasing body fat and increasing prostate size drawing the penis back into the body,' he told diabetes.co.
Dr. Richard Viney thinks weight-loss drugs, like Ozempic could be to blame for increased penis size.
Christopher Sadowski
Advertisement
'It is theoretically possible that new drugs like Ozempic and Wegovy, which are used to treat diabetes and obesity, respectively and can cause people to lose weight, could also be a factor. As men lose weight, their penises appear larger.'
However, in 2023, research published in the World Journal of Men's Health revealed that the average size of what a guy is packing has grown 24% over nearly 30 years.
And that sort of increase has health experts concerned — especially because even two years ago, they couldn't put their finger on what the cause of it is.
Advertisement
Speculation around weight loss drugs being the culprit is possible — but the Ozempic trend is recent, and this growth for men has clearly been going on for some time now.
'Any overall change in development is concerning, because our reproductive system is one of the most important pieces of human biology,' Dr. Michael Eisenberg, the study's author, told Stanford Medicine's blog Scope.
'If we're seeing this fast of a change, it means that something powerful is happening to our bodies.'
Other possible causes could be chemical exposure from pesticides or hygiene products, Eisenberg hypothesized, which can disrupt the hormone-regulating endocrine system.
Time will only tell if Ozempic or other lifestyle factors are to blame for well-endowed men.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Concerned Father Believes His Son, 23, Hasn't Left His Apartment in Over a Year
A father on Reddit is worried about his son, who he thinks has not left his apartment in a year The dad visited his son to check in on him, though his son refused to go outside and talk with him The poster is considering calling another wellness check on his son out of concern over his isolating behaviorA father on Reddit has grown increasingly worried about his son, who he believes hasn't left his apartment in a year. On Reddit's r/AmIOverreacting forum, the 47-year-old father writes that he hasn't seen his son in a year, with their last in-person interaction taking place at his graduation. Though he's extended invites to family holiday gatherings, like Thanksgiving and Christmas, his son has declined the invites or not responded at all. "I started getting really worried after Easter, mid April," the dad writes, noting that he called for a wellness check soon after. "They said that he 'seemed fine.' I tried to go out there to talk to him, and he would not open the door," the dad continues. "He only talked to me through the crack of the door. Hearing his voice actually calmed me a bit. But even then he just told me that he couldn't go outside to talk to me." The father notes that he and his son "used to be pretty close," but now feels like his son is trying to "cut [him] off" without explicitly saying so. He and his wife last heard from the 23-year-old on Mother's Day, when the college graduate reached out with a "simple text." "We tried to get him to engage in a conversation. We asked if he'd be coming for dinner. No response," the dad writes. "Now it's been over a year since we think he last left the house," he continues, admitting that "this might be where I'm starting to overreact." The Redditor also asked some of his son's longtime friends "if they've been out with him in the past year," but they told him "they haven't even been able to reach him." "This was a pattern across the friends I asked," the dad writes. "One even said he told her to flat out stop calling." The Reddit user's wife insists that their son may just be busy trying to find a job, prompting his distance, though he's hesitant to believe that's the only factor in their son's sudden reclusive behavior. "I understand that online interviews exist but I cannot grasp the idea that he is looking for a job," the father continues. "If he didn't go outside to talk to me then it's not likely that he would leave to go to a job interview." The worried father also notes that he and his wife have been paying for their son's apartment. In replies to the comments on the post, he explains that their original intention was to "cut him off" after he graduated, though their concern has stopped them from pulling the plug financially. "He has no sense of urgency as my wife and I have been paying for the apartment since he started college so we could make sure he was safe and didn't have debts," he continues. "Before this, my son was very extroverted and active. I don't think we ever spent the majority of a day inside when he was growing up." Read the original article on People


New York Post
4 hours ago
- New York Post
Average penis size has increased — and Ozempic could be to blame, experts say
Ozempic might shrink waistlines, but it seems to bulge another body part. In a recent Reddit thread, male Ozempic users claimed that the weight-loss drugs helped their penises grow. 'I recently measured myself down there and noticed I gained about one inch,' a person proudly shared on the forum. Advertisement Although there hasn't been enough research done on the correlation between semaglutide and men's genitalia measurements — the average penis size is continuing to rise, and some experts think Ozempic might actually have something to do with it. The average penis has grown nearly 10% from 5.17 inches to 5.63 between 2022 and 2024 in the UK, according to And they're not the only ones seeing this increase. Advertisement The data also revealed that Venezuelan men experienced a massive increase from 1.42 inches to 6.67 inches, within those two years. Dr. Richard Viney, a consultant urological surgeon at the Queen Elizabeth Hospital in Birmingham, thinks Ozempic and similar drugs could be to blame. 'Men's penises shorten as they get older (due to) increasing body fat and increasing prostate size drawing the penis back into the body,' he told Dr. Richard Viney thinks weight-loss drugs, like Ozempic could be to blame for increased penis size. Christopher Sadowski Advertisement 'It is theoretically possible that new drugs like Ozempic and Wegovy, which are used to treat diabetes and obesity, respectively and can cause people to lose weight, could also be a factor. As men lose weight, their penises appear larger.' However, in 2023, research published in the World Journal of Men's Health revealed that the average size of what a guy is packing has grown 24% over nearly 30 years. And that sort of increase has health experts concerned — especially because even two years ago, they couldn't put their finger on what the cause of it is. Advertisement Speculation around weight loss drugs being the culprit is possible — but the Ozempic trend is recent, and this growth for men has clearly been going on for some time now. 'Any overall change in development is concerning, because our reproductive system is one of the most important pieces of human biology,' Dr. Michael Eisenberg, the study's author, told Stanford Medicine's blog Scope. 'If we're seeing this fast of a change, it means that something powerful is happening to our bodies.' Other possible causes could be chemical exposure from pesticides or hygiene products, Eisenberg hypothesized, which can disrupt the hormone-regulating endocrine system. Time will only tell if Ozempic or other lifestyle factors are to blame for well-endowed men.


The Hill
11 hours ago
- The Hill
Beyond MAHA: Defeating obesity requires a new strategy
Obesity is a major health problem facing our country. According to the CDC, more than 40 percent of the U.S. population is obese, defined as having a body-mass index above 30. As astounding at that number is, it is perhaps even more surprising that nearly 20 percent of children in the U.S. are obese. Obesity leads to significant health challenges, including diabetes, stroke, cardiovascular disease and liver disease. It is clear that as a nation we must face this crisis on multiple fronts. Diet and exercise certainly help, and it's critical to ensure that people of all socioeconomic backgrounds have access to healthy foods (free of preservatives, unnecessary dyes, high fructose corn syrups etc.) and are educated in making healthy lifestyle choices. The MAHA or 'Make America Healthy Again' movement has highlighted this as one of its key objectives, and if it is successful, we should see an impact on obesity — especially in children, where diet and exercise have a huge impact on weight-related health outcomes. Obesity in adults, however, is often more challenging. Many adults with obesity struggle to lose weight, despite considerable efforts to modify their lifestyle through diet and exercise. This is because our metabolism changes as we age, and many adults who are overweight develop metabolic dysfunction or 'metabolic syndrome,' which then further perpetuates weight gain and exacerbates the situation. It has become clear in recent years that many people struggling with obesity require medical intervention – not just lifestyle intervention – and that prescriptions can substantially improve weight loss. The explosion in use of GLP-1 agonists, such as Wegovy and Zepbound, over the last two years has underscored the need for medical intervention in obese and overweight patients. Currently, about 6 percent of the U.S. population, or 15 million people, are on GLP-1 weight loss treatments, and the numbers are only expected to increase. However, while most patients lose 10 percent to 25 percent of their body weight while on a GLP-1, they do not maintain GLP-1 treatment in the long-term, with approximately 80 percent of patients discontinuing treatment within 1 year. Gastrointestinal side effects, injectable administration, and high cost have prevented long-term use of GLP-1's for weight maintenance. And unfortunately, most patients gain back all the weight after stopping the medication. Healthcare professionals and the pharmaceutical industry now recognize that obesity — like most other medical conditions — requires an 'arsenal' of treatments, rather than a one-size-fits-all approach. Post-GLP-1 weight maintenance is now widely recognized as an emerging unmet need. And patients who are not candidates for or cannot tolerate GLP-1s require alternatives. Diet and lifestyle modifications are important alongside prescription medications in fighting obesity. If we are going to be successful in overcoming this major health crisis, we need to ensure that both the pharmaceutical industry and groups like MAHA work hand in hand. Both treatment and prevention are critical in order to regain control of our nation's health. Dr. Shoshana Shendelman, Ph.D. is a scientist and entrepreneur who has founded numerous biotech companies. She is a pioneer in the development of drugs and therapeutics for rare and underserved diseases. Currently she is Vice Chair of the Advisory Board of Columbia University Medical Center and Columbia University Vagelos College of Physicians and Surgeons.